Patents by Inventor Eric Gaudreault

Eric Gaudreault has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10343637
    Abstract: An airbag bracket assembly includes a seat frame including a stud hole, a first bracket, and a second bracket including a bracket hole. The first bracket is located on one side of the seat frame, and the second bracket is located on an opposing side of the seat frame. A fastener is attached to the first bracket. The fastener is received in the stud hole and the bracket hole. A method is also disclosed.
    Type: Grant
    Filed: July 5, 2016
    Date of Patent: July 9, 2019
    Assignee: Toyota Boshoku America, Inc.
    Inventors: Alice Knoebel, Blair Kinsman, Eric Gaudreault
  • Publication number: 20170151204
    Abstract: The present invention relates to the use of leukotriene B4 to enhance the response of Toll-like receptor (TLR), RIG-I-like receptor (RLR), and NOD-like receptor (NLR) when stimulated simultaneously with respective proper ligands. The use in combination of LTB4 with those ligands is useful to potentiate immune response for the treatment of autoimmune diseases, immunosuppressive diseases, as well as immunological disorders.
    Type: Application
    Filed: February 10, 2017
    Publication date: June 1, 2017
    Inventors: Jean Gosselin, Eric Gaudreault
  • Publication number: 20170008476
    Abstract: An airbag bracket assembly includes a seat frame including a stud hole, a first bracket, and a second bracket including a bracket hole. The first bracket is located on one side of the seat frame, and the second bracket is located on an opposing side of the seat frame. A fastener is attached to the first bracket. The fastener is received in the stud hole and the bracket hole. A method is also disclosed.
    Type: Application
    Filed: July 5, 2016
    Publication date: January 12, 2017
    Inventors: Alice Knoebel, Blair Kinsman, Eric Gaudreault
  • Publication number: 20130236496
    Abstract: The present invention relates to the use of leukotriene B4 to enhance the response of Toll-like receptor (TLR), RIG-I-like receptor (RLR), and NOD-like receptor (NLR) when stimulated simultaneously with respective proper ligands. The use in combination of LTB4 with those ligands is useful to potentiate immune response for the treatment of autoimmune diseases, immunosuppressive diseases, as well as immunological disorders.
    Type: Application
    Filed: June 20, 2011
    Publication date: September 12, 2013
    Applicant: UNIVERSITE DE LAVAL
    Inventors: Jean Gosselin, Eric Gaudreault